Recommended

Lilly to sell Branchburg site as its global manufacturing plans take shape
Bristol Myers Squibb names new Head of Development
Sanofi strikes $1.6 bn respiratory vaccine deal
Lilly’s Alzheimer’s drug demonstrates long-term benefit
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
Decentralised manufacturing world-first with new UK legislation
Key trends shaping the pharma landscape in Q3 2025
Transforming pharma manufacturing with digital tools
Webinar

Optimise fermentation processes by implementing respiratory gas analysis PAT

15 December 2022

Shares

14

Watch on-demand to learn how Sanofi utilises online process mass spectrometry for continuous respiratory gas analysis to improve process insight and drive better outcomes.

About this on-demand webinar

Respiratory gas analysis is a non-invasive way of characterising a fermentation or cell culture process.

Over many years Thermo Scientific™ Gas Analysis Mass Spectrometers have proven effective in monitoring bacterial and microbial processes. More recently, there has been increasing interest in mammalian cell cultures because they offer the prospect of radical advances in vaccines, monoclonal antibodies and gene therapy. Analysis of the respiratory gases being fed into and produced from fermentations and cell cultures is an ideal way of characterising the behaviour and productivity of the cells during the process. 

Hear from Marie Izac, Vaccine Drug Substance Unit Head at Sanofi and Dan Merriman of Thermo Fisher Scientific, who discusses how Sanofi utilises online mass spectrometry for continuous respiratory gas analysis to improve process insight and drive better outcomes.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Key takeaways

  • The simplicity of implementing high quality respiratory gas analysis by MS
  • How MS is a flexible and reliable method for determining critical process parameters
  • Discover how MS has moved into the mainstream for process analytics.

Our speakers

Marie Izac, Vaccine Drug Substance Unit Head, Sanofi Pasteur

Marie graduated from a French Engineering school in Industrial Microbiology and completed it with PhD on pathogenic bacteria physiology and metabolism. She joined Sanofi in 2016 and progressed from Upstream Scientist to an Upstream/Downstream manager position. She has strong expertise in bioprocess.

Daniel Merriman, Strategic Marketing, Thermo Fisher Scientific

Daniel Merriman has worked in the field of process analytics since joining the former VG Instruments business in 1988 now a part of Thermo Fisher Scientific. After holding many positions in technical, sales and marketing, Daniel is now supporting the strategic marketing group within the Environmental and Process Monitoring business of Thermo Fisher Scientific.

 

 

Share via